867 related articles for article (PubMed ID: 23978709)
1. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
2. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
4. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
[TBL] [Abstract][Full Text] [Related]
5. [Case analysis on treatment and recurrence of giant cell tumor of bone].
Zhang Z; Zhu B; Sun T
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
[TBL] [Abstract][Full Text] [Related]
6. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
[TBL] [Abstract][Full Text] [Related]
7. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
8. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin use in giant cell bone tumors.
Nouri H; Hedi Meherzi M; Ouertatani M; Mestiri M; Zehi K; Douik M; Zouari M
Orthop Traumatol Surg Res; 2011 Sep; 97(5):520-6. PubMed ID: 21723215
[TBL] [Abstract][Full Text] [Related]
10. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?
Gaston CL; Bhumbra R; Watanuki M; Abudu AT; Carter SR; Jeys LM; Tillman RM; Grimer RJ
J Bone Joint Surg Br; 2011 Dec; 93(12):1665-9. PubMed ID: 22161931
[TBL] [Abstract][Full Text] [Related]
11. Ethanol as a local adjuvant for giant cell tumor of bone.
Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
[TBL] [Abstract][Full Text] [Related]
13. Functional results after giant cell tumor operation near knee joint and the cement radiolucent zone as indicator of recurrence.
Kafchitsas K; Habermann B; Proschek D; Kurth A; Eberhardt C
Anticancer Res; 2010 Sep; 30(9):3795-9. PubMed ID: 20944172
[TBL] [Abstract][Full Text] [Related]
14. Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.
Lackman RD; Crawford EA; King JJ; Ogilvie CM
Clin Orthop Relat Res; 2009 May; 467(5):1355-9. PubMed ID: 18987923
[TBL] [Abstract][Full Text] [Related]
15. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
[TBL] [Abstract][Full Text] [Related]
16. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
[TBL] [Abstract][Full Text] [Related]
18. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
[TBL] [Abstract][Full Text] [Related]
19. [Multicentric giant cell tumor: clinical analysis of 9 cases].
Li X; Guo W; Yang RL; Yang Y
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3602-5. PubMed ID: 24534311
[TBL] [Abstract][Full Text] [Related]
20. The outcomes of treatment of giant cell tumor of bone around the knee.
Asavamongkolkul A; Eamsobhana P; Waikakul S; Phimolsarnti R
J Med Assoc Thai; 2012 Sep; 95 Suppl 9():S122-8. PubMed ID: 23326994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
